Comparison of Clinical Outcomes Between Calfactant and Poractant-Alfa in Preterm Infants with Respiratory Distress Syndrome
Bibliographic Data
| ID | 15712652 |
|---|---|
| Authors | Leyla Şero (0000-0001-5224-8583, Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi, corresponding author), Nilüfer Okur (0000-0003-3897-5826, Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi), Duygu Tunçel (0000-0002-2130-6821, Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi) |
| Year | 2025 |
| Volume | 12 |
| Issue | 10 |
| Pages | 1350-1350 |
| Publication date | 2025-10-08 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Children (JOURNAL) |
| Journal identifiers | ISSN: 2227-9067 • E-ISSN: 2227-9067 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/children12101350 |
| PMID | 41153532 |
| OpenAlex | W4414947911 |
| Language | EN |
Compared with calfactant, poractant alfa offers practical advantages-such as a higher initial dose, lower cost, and reduced need for a second repeat dose-while yielding comparable short- and mid-term morbidity and mortality outcomes
Distress · Incidence (geometry · MEDLINE · Population · Respiratory distress · Infant Development and Preterm Care · Neonatal Respiratory Health Research · Neuroscience of respiration and sleep
| Highly cited | No |
|---|